The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-N-(4-(2-(3-methoxy-4-(2-(pyrrolidin-1-yl)ethoxy)benzylidene)hydrazinecarbonyl)phenyl)benzamide ID: ALA3394913
PubChem CID: 118726352
Max Phase: Preclinical
Molecular Formula: C28H30N4O4
Molecular Weight: 486.57
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(/C=N/NC(=O)c2ccc(NC(=O)c3ccccc3)cc2)ccc1OCCN1CCCC1
Standard InChI: InChI=1S/C28H30N4O4/c1-35-26-19-21(9-14-25(26)36-18-17-32-15-5-6-16-32)20-29-31-28(34)23-10-12-24(13-11-23)30-27(33)22-7-3-2-4-8-22/h2-4,7-14,19-20H,5-6,15-18H2,1H3,(H,30,33)(H,31,34)/b29-20+
Standard InChI Key: FIDCSAAIHNKBJM-ZTKZIYFRSA-N
Molfile:
RDKit 2D
36 39 0 0 0 0 0 0 0 0999 V2000
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5972 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5951 -3.0039 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.6375 -0.9049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8934 -5.2570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1924 -6.0071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4914 -5.2571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.4915 -3.7571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1925 -3.0071 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.7927 -6.0049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.0914 -5.2527 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.7948 -7.2049 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-10.3927 -6.0004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-11.6914 -5.2482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9927 -5.9960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.2918 -5.2460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-15.5908 -5.9960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-15.5908 -7.4960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.2918 -8.2460 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-12.9927 -7.4960 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-14.2887 -9.7469 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-13.2486 -10.3454 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-16.8921 -8.2438 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-18.1908 -7.4915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-19.4921 -8.2393 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-20.7908 -7.4870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-22.1443 -8.1033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-23.1441 -6.9851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-22.3896 -5.6887 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-20.9235 -6.0057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 1 0
10 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 10 1 0
13 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
25 27 1 0
27 28 1 0
24 29 1 0
29 30 1 0
30 31 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
35 36 1 0
36 32 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 486.57Molecular Weight (Monoisotopic): 486.2267AlogP: 4.19#Rotatable Bonds: 10Polar Surface Area: 92.26Molecular Species: BASEHBA: 6HBD: 2#RO5 Violations: ┄HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.51CX Basic pKa: 8.53CX LogP: 4.05CX LogD: 3.00Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.33Np Likeness Score: -1.47
References 1. Miknis GF, Stevens SJ, Smith LE, Ostrov DA, Churchill ME.. (2015) Development of novel Asf1-H3/H4 inhibitors., 25 (4): [PMID:25582598 ] [10.1016/j.bmcl.2014.11.067 ] 2. Miknis, Greg F; Stevens, Sarah J; Smith, Luke E; Ostrov, David A and Churchill, Mair E A. 2015-02-15 Development of novel Asf1-H3/H4 inhibitors. [PMID:25582598 ]